Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials

Y Cheng, C He, M Wang, X Ma, F Mo, S Yang… - Signal transduction and …, 2019 - nature.com
Epigenetic alternations concern heritable yet reversible changes in histone or DNA
modifications that regulate gene activity beyond the underlying sequence. Epigenetic …

Targeting epigenetic regulators to overcome drug resistance in cancers

N Wang, T Ma, B Yu - Signal transduction and targeted therapy, 2023 - nature.com
Drug resistance is mainly responsible for cancer recurrence and poor prognosis. Epigenetic
regulation is a heritable change in gene expressions independent of nucleotide sequence …

Histone demethylases in chromatin biology and beyond

E Dimitrova, AH Turberfield, RJ Klose - EMBO reports, 2015 - embopress.org
Histone methylation plays fundamental roles in regulating chromatin‐based processes. With
the discovery of histone demethylases over a decade ago, it is now clear that histone …

Histone lysine demethylases and their functions in cancer

J Sterling, SV Menezes, RH Abbassi… - International Journal of …, 2021 - Wiley Online Library
Histone lysine demethylases (KDMs) are enzymes that remove the methylation marks on
lysines in nucleosomes' histone tails. These changes in methylation marks regulate gene …

Cooperative dynamics of AR and ER activity in breast cancer

NC D'Amato, MA Gordon, B Babbs, NS Spoelstra… - Molecular cancer …, 2016 - AACR
Androgen receptor (AR) is expressed in 90% of estrogen receptor alpha–positive (ER+)
breast tumors, but its role in tumor growth and progression remains controversial. Use of two …

Hallmarks of sex bias in immuno-oncology: mechanisms and therapeutic implications

T Xiao, J Lee, TD Gauntner, M Velegraki… - Nature Reviews …, 2024 - nature.com
Sex differences are present across multiple non-reproductive organ cancers, with male
individuals generally experiencing higher incidence of cancer with poorer outcomes …

[HTML][HTML] The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells

S Wilson, L Fan, N Sahgal, J Qi, FV Filipp - Oncotarget, 2017 - ncbi.nlm.nih.gov
The lysine demethylase 3A (KDM3A, JMJD1A or JHDM2A) controls transcriptional networks
in a variety of biological processes such as spermatogenesis, metabolism, stem cell activity …

Advances in histone demethylase KDM3A as a cancer therapeutic target

J Yoo, YH Jeon, HY Cho, SW Lee, GW Kim, DH Lee… - Cancers, 2020 - mdpi.com
Lysine-specific histone demethylase 3 (KDM3) subfamily proteins are H3K9me2/me1
histone demethylases that promote gene expression. The KDM3 subfamily primarily consists …

The histone demethylase KDM3A, increased in human pancreatic tumors, regulates expression of DCLK1 and promotes tumorigenesis in mice

P Dandawate, C Ghosh, K Palaniyandi, S Paul… - Gastroenterology, 2019 - Elsevier
Background & Aims The histone lysine demethylase 3A (KDM3A) demethylates H3K9me1
and H3K9Me2 to increase gene transcription and is upregulated in tumors, including …

Histone demethylase JMJD1A promotes urinary bladder cancer progression by enhancing glycolysis through coactivation of hypoxia inducible factor 1α

W Wan, K Peng, M Li, L Qin, Z Tong, J Yan, B Shen… - Oncogene, 2017 - nature.com
High aerobic glycolysis not only provides energy to cancer cells, but also supports their
anabolic growth. JMJD1A, a histone demethylase that specifically demethylates …